查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968607

抗菌素抗藥性監測市場分析及預測（至2035年）：類型、產品類型、服務、技術、組件、應用、最終用戶、解決方案和部署類型

Antimicrobial Resistance Surveillance Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Solutions, Deployment
出版日期: | 出版商: Global Insight Services | 英文 301 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計抗菌素抗藥性監測市場將從2024年的95億美元成長到2034年的153億美元，複合年成長率約為4.9%。抗菌素抗藥性監測市場涵蓋用於監測和分析病原體抗藥性模式的系統和調查方法。該市場包括數據收集、實驗室檢測和報告工具，這些工具對於公共衛生和藥物策略至關重要。抗菌素抗藥性的日益嚴重推動了對先進監測技術的需求，這些技術能夠實現及時干預和政策制定。推動該市場發展的動力來自於全球在診斷工具和數據分析方面的合作與創新，以有效應對抗藥性趨勢。

由於迫切需要對抗抗藥性病原體，抗菌藥物抗藥性（AMR）監測市場正經歷強勁成長。診斷設備領域是推動這一成長的主要動力，其中快速診斷測試和次世代定序技術發揮關鍵作用。這些技術能夠快速識別抗藥性菌株，這對制定有效的治療策略至關重要。軟體和服務領域也緊隨其後，這主要得益於數據分析平台和雲端監測系統的日益普及。這些工具能夠實現即時數據共用和預測分析，從而加強全球監測工作。在診斷設備細分領域，就地檢驗設備憑藉其便利性和快速性，在各種醫療環境中脫穎而出，成為表現最佳的產品。檢查室診斷設備憑藉其準確性和全面的檢測能力，成為成長第二快的細分領域。抗菌藥物抗藥性（AMR）的日益普遍以及全球協調應對的必要性凸顯了這些技術進步的重要性，並為這一重要市場的相關人員提供了盈利的機會。

市場區隔
按類型 病原體特異性監測、藥物特異性監測、檢查室監測、以地區為基礎監測、醫院監測、獸醫監測、環境監測
產品 軟體、資料庫、試劑、設備、耗材、試劑盒、檢測方法
服務 資料管理、諮詢、培訓與教育、檢驗服務、外包服務
科技 分子診斷、免疫檢測、微生物培養、質譜分析、次世代定序、聚合酵素鏈鎖反應（PCR）
成分 資料收集工具、資料分析工具和報告工具
應用領域 臨床診斷、藥物發現與開發、公共衛生監測、流行病學研究
最終用戶 醫院/診所、診斷檢查室、製藥公司、研究機構、政府機構、獸醫診所
解決方案 整合監控系統、獨立解決方案、雲端解決方案、本地部署解決方案
實施表格 雲端、本地部署、混合部署

市場概況：

抗菌藥物抗藥性監測市場正經歷動態變化，市場佔有率、定價和新產品推出均呈現顯著發展趨勢。該市場以創新監測解決方案為特徵，旨在滿足日益成長的抗菌藥物抗藥性監測需求。主要企業正策略性地推出先進產品並強化產品系列，以滿足不斷變化的消費者需求。價格競爭日益激烈，各企業紛紛利用成本效益策略取得競爭優勢。抗菌藥物抗藥性的日益普遍導致對強大監測系統的需求不斷成長，從而推動了市場成長。競爭格局的特徵是主要企業之間的激烈競爭，尤其注重技術創新和策略合作。監管影響至關重要，嚴格的指導方針塑造市場動態並確保合規性。北美和歐洲憑藉先進的醫療保健基礎設施和支援性的法規結構處於領先地位。亞太地區由於醫療保健投資的增加和宣傳活動的加強，正崛起為一個充滿潛力的市場。分子診斷技術和即時數據分析的進步預計將推動顯著成長，預示著該市場前景光明。

主要趨勢和促進因素：

由於人們日益認知到抗菌素抗藥性（AMR）是全球健康威脅，AMR監測市場正經歷強勁成長。關鍵趨勢包括整合先進的數據分析和人工智慧技術以增強監測能力。這項技術進步能夠更精確地追蹤抗藥性模式，有助於及時採取干涉措施。各國政府和國際組織都意識到合作的重要性，正在加大對AMR監測基礎設施的投資。不斷擴大的公私合營正在促進創新和資源共用，進一步加速市場發展。此外，多重抗藥性感染疾病的日益普遍也推動了對綜合監測解決方案的需求。新興經濟體醫療基礎設施的擴張也對市場產生影響，因為AMR控制已成為這些國家的優先事項。對於提供擴充性且經濟高效的監測技術的公司而言，存在著眾多機會。隨著全球醫療政策不斷強調AMR控制的重要性，由於醫療需求快速成長的地區蘊藏著巨大的潛力，預計該市場將持續成長。

限制與挑戰：

抗生素抗藥性監測市場面臨許多重大限制和挑戰。其中一項主要挑戰是實施先進監測系統高成本，這阻礙了其在低收入國家和小規模醫療機構的廣泛應用。許多機構仍依賴過時的方法，導致數據不一致，抗藥性模式監測不足。此外，人們普遍缺乏對抗生素抗藥性監測重要性的認知和教育，導致其價值被低估。一些地區政府資金和支持不足，進一步阻礙了市場擴張。另外，抗藥性機制的複雜性需要專業知識，這類知識往往短缺，使得數據分析和解讀困難重重。不同平台和地區間的資料共用和整合也面臨挑戰，阻礙了全面的監測活動。此外，諸如資料收集和傳輸的及時性等後勤問題，也可能導致延誤，降低抗藥性追蹤的有效性。所有這些因素共同阻礙了抗生素抗藥性監測市場的成長和有效性。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 病原體特異性監測
    • 藥物特異性監測
    • 檢查室監測
    • 以地區為基礎監測
    • 醫院監測
    • 獸醫監測
    • 環境監測
  • 市場規模及預測：依產品分類
    • 軟體
    • 資料庫
    • 試劑
    • 裝置
    • 消耗品
    • 成套工具
    • 偵測
  • 市場規模及預測：依服務分類
    • 資料管理
    • 諮詢
    • 培訓和教育
    • 檢查室服務
    • 外包服務
  • 市場規模及預測：依技術分類
    • 分子診斷
    • 免疫檢測
    • 微生物培養
    • 質譜分析
    • 次世代定序
    • 聚合酵素鏈鎖反應（PCR）
  • 市場規模及預測：依組件分類
    • 資料收集工具
    • 數據分析工具
    • 報告工具
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 藥物發現與開發
    • 公共衛生監測
    • 流行病學研究
  • 市場規模及預測：依最終用戶分類
    • 醫院和診所
    • 診斷檢查室
    • 製藥公司
    • 研究所
    • 政府機構
    • 獸醫診所
  • 市場規模及預測：按解決方案分類
    • 整合監測系統
    • 獨立解決方案
    • 基於雲端的解決方案
    • 本地部署解決方案
  • 市場規模及預測：依發展狀況
    • 雲
    • 本地部署
    • 混合

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • bioMerieux
  • Thermo Fisher Scientific
  • Luminex Corporation
  • Alere Inc
  • OpGen
  • Accelerate Diagnostics
  • Meridian Bioscience
  • T2 Biosystems
  • Mobidiag
  • Becton Dickinson
  • Roche Diagnostics
  • Siemens Healthineers
  • Bruker Corporation
  • Qiagen
  • Abbott Laboratories

第9章：關於我們

簡介目錄
Product Code: GIS33633

Antimicrobial Resistance Surveillance Market is anticipated to expand from $9.5 billion in 2024 to $15.3 billion by 2034, growing at a CAGR of approximately 4.9%. The Antimicrobial Resistance Surveillance Market encompasses systems and methodologies for monitoring and analyzing resistance patterns in pathogens. This market includes data collection, laboratory testing, and reporting tools essential for public health and pharmaceutical strategies. With rising antimicrobial resistance, demand is increasing for advanced surveillance technologies that enable timely interventions and policy-making. The market is driven by the need for global collaboration and innovation in diagnostic tools and data analytics to effectively combat resistance trends.

The Antimicrobial Resistance (AMR) Surveillance Market is experiencing robust growth, propelled by the urgent need to combat antibiotic-resistant pathogens. The diagnostic devices segment leads in performance, with rapid diagnostic tests and next-generation sequencing technologies playing pivotal roles. These technologies enable swift identification of resistant strains, crucial for effective treatment strategies. The software and services segment follows closely, driven by the increasing adoption of data analytics platforms and cloud-based surveillance systems. These tools facilitate real-time data sharing and predictive analytics, enhancing global surveillance efforts. Within the diagnostic devices sub-segment, point-of-care testing devices are emerging as top performers, offering convenience and speed in diverse healthcare settings. Laboratory-based diagnostic devices are anticipated as the second highest-performing sub-segment, given their accuracy and comprehensive testing capabilities. The rising prevalence of AMR and the need for coordinated global responses underscore the importance of these advancements, presenting lucrative opportunities for stakeholders in this critical market.

Market Segmentation
TypePathogen-specific Surveillance, Drug-specific Surveillance, Laboratory-based Surveillance, Community-based Surveillance, Hospital-based Surveillance, Veterinary Surveillance, Environmental Surveillance
ProductSoftware, Databases, Reagents, Instruments, Consumables, Kits, Assays
ServicesData Management, Consulting, Training and Education, Laboratory Services, Outsourcing Services
TechnologyMolecular Diagnostics, Immunoassays, Microbial Culture, Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction (PCR)
ComponentData Collection Tools, Data Analysis Tools, Reporting Tools
ApplicationClinical Diagnostics, Drug Discovery and Development, Public Health Surveillance, Epidemiological Studies
End UserHospitals and Clinics, Diagnostic Laboratories, Pharmaceutical Companies, Research Institutes, Government Agencies, Veterinary Clinics
SolutionsIntegrated Surveillance Systems, Standalone Solutions, Cloud-based Solutions, On-premise Solutions
DeploymentCloud, On-Premises, Hybrid

Market Snapshot:

Antimicrobial Resistance Surveillance Market is witnessing a dynamic shift with significant strides in market share, pricing, and new product launches. The market is characterized by innovative surveillance solutions that cater to the burgeoning demand for effective antimicrobial resistance monitoring. Key players are strategically launching advanced products, enhancing their portfolios to meet evolving consumer needs. The pricing landscape is competitive, with companies leveraging cost-effective strategies to gain a competitive edge. The market's growth is underpinned by the increasing prevalence of antimicrobial resistance, driving the need for robust surveillance systems. The competitive landscape is marked by intense rivalry among leading firms, with a strong emphasis on technological innovation and strategic collaborations. Regulatory influences play a pivotal role, with stringent guidelines shaping market dynamics and ensuring compliance. North America and Europe are at the forefront, driven by sophisticated healthcare infrastructures and supportive regulatory frameworks. The Asia-Pacific region is emerging as a lucrative market, propelled by rising healthcare investments and awareness initiatives. The market's future is promising, with advancements in molecular diagnostics and real-time data analytics poised to drive substantial growth.

Geographical Overview:

The Antimicrobial Resistance (AMR) Surveillance Market is witnessing significant expansion across diverse regions, each presenting unique growth opportunities. North America remains at the forefront, propelled by robust healthcare infrastructure and increased governmental initiatives to combat AMR. The region's focus on advanced technologies and data integration further accelerates market development. Europe is closely following, benefitting from strong regulatory frameworks and collaborative efforts among nations to address AMR challenges. In Asia Pacific, the market is experiencing rapid growth, driven by rising healthcare investments and the increasing burden of AMR. Countries like India and China are emerging as pivotal players, with substantial investments in surveillance systems and public health initiatives. Latin America and the Middle East & Africa are also witnessing growing potential. In Latin America, increased awareness and healthcare funding are fostering market expansion, while the Middle East & Africa are focusing on strengthening health systems to address AMR effectively.

Key Trends and Drivers:

The Antimicrobial Resistance (AMR) Surveillance Market is experiencing robust growth due to heightened awareness of AMR's global health threat. Key trends include the integration of advanced data analytics and artificial intelligence to enhance surveillance capabilities. This technological evolution is enabling more precise tracking of resistance patterns and facilitating timely interventions. Governments and international organizations are increasingly investing in AMR surveillance infrastructure, recognizing the critical need for coordinated efforts. The rise of public-private partnerships is fostering innovation and resource sharing, further propelling market development. Additionally, the growing prevalence of multi-drug resistant infections is driving demand for comprehensive surveillance solutions. The market is also influenced by the expansion of healthcare infrastructure in emerging economies, which are prioritizing AMR initiatives. Opportunities abound for companies offering scalable and cost-effective surveillance technologies. As global health policies continue to emphasize AMR mitigation, the market is poised for sustained growth, with significant potential in regions with burgeoning healthcare needs.

Restraints and Challenges:

The Antimicrobial Resistance Surveillance Market encounters several significant restraints and challenges. A primary challenge is the high cost of implementing sophisticated surveillance systems, which hampers adoption in low-income countries and smaller healthcare facilities. Many institutions still rely on outdated methods, leading to inconsistent data and inadequate monitoring of resistance patterns. Moreover, there is a pervasive lack of awareness and education about the importance of antimicrobial resistance surveillance, which diminishes its perceived value. In several regions, insufficient government funding and support further inhibit market expansion. Additionally, the complexity of resistance mechanisms necessitates specialized expertise, which is often scarce, complicating data analysis and interpretation. The market also faces challenges related to data sharing and integration across different platforms and regions, which restricts comprehensive surveillance efforts. Furthermore, logistical issues, such as timely data collection and transmission, can cause delays, reducing the efficacy of resistance tracking. These factors collectively impede the growth and effectiveness of the antimicrobial resistance surveillance market.

Key Players:

bioMerieux, Thermo Fisher Scientific, Luminex Corporation, Alere Inc, OpGen, Accelerate Diagnostics, Meridian Bioscience, T2 Biosystems, Mobidiag, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, Bruker Corporation, Qiagen, Abbott Laboratories

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Solutions
  • 2.9 Key Market Highlights by Deployment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Pathogen-specific Surveillance
    • 4.1.2 Drug-specific Surveillance
    • 4.1.3 Laboratory-based Surveillance
    • 4.1.4 Community-based Surveillance
    • 4.1.5 Hospital-based Surveillance
    • 4.1.6 Veterinary Surveillance
    • 4.1.7 Environmental Surveillance
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software
    • 4.2.2 Databases
    • 4.2.3 Reagents
    • 4.2.4 Instruments
    • 4.2.5 Consumables
    • 4.2.6 Kits
    • 4.2.7 Assays
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Data Management
    • 4.3.2 Consulting
    • 4.3.3 Training and Education
    • 4.3.4 Laboratory Services
    • 4.3.5 Outsourcing Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Molecular Diagnostics
    • 4.4.2 Immunoassays
    • 4.4.3 Microbial Culture
    • 4.4.4 Mass Spectrometry
    • 4.4.5 Next-Generation Sequencing
    • 4.4.6 Polymerase Chain Reaction (PCR)
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Data Collection Tools
    • 4.5.2 Data Analysis Tools
    • 4.5.3 Reporting Tools
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Diagnostics
    • 4.6.2 Drug Discovery and Development
    • 4.6.3 Public Health Surveillance
    • 4.6.4 Epidemiological Studies
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals and Clinics
    • 4.7.2 Diagnostic Laboratories
    • 4.7.3 Pharmaceutical Companies
    • 4.7.4 Research Institutes
    • 4.7.5 Government Agencies
    • 4.7.6 Veterinary Clinics
  • 4.8 Market Size & Forecast by Solutions (2020-2035)
    • 4.8.1 Integrated Surveillance Systems
    • 4.8.2 Standalone Solutions
    • 4.8.3 Cloud-based Solutions
    • 4.8.4 On-premise Solutions
  • 4.9 Market Size & Forecast by Deployment (2020-2035)
    • 4.9.1 Cloud
    • 4.9.2 On-Premises
    • 4.9.3 Hybrid

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Solutions
      • 5.2.1.9 Deployment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Solutions
      • 5.2.2.9 Deployment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Solutions
      • 5.2.3.9 Deployment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Solutions
      • 5.3.1.9 Deployment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Solutions
      • 5.3.2.9 Deployment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Solutions
      • 5.3.3.9 Deployment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Solutions
      • 5.4.1.9 Deployment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Solutions
      • 5.4.2.9 Deployment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Solutions
      • 5.4.3.9 Deployment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Solutions
      • 5.4.4.9 Deployment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Solutions
      • 5.4.5.9 Deployment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Solutions
      • 5.4.6.9 Deployment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Solutions
      • 5.4.7.9 Deployment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Solutions
      • 5.5.1.9 Deployment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Solutions
      • 5.5.2.9 Deployment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Solutions
      • 5.5.3.9 Deployment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Solutions
      • 5.5.4.9 Deployment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Solutions
      • 5.5.5.9 Deployment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Solutions
      • 5.5.6.9 Deployment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Solutions
      • 5.6.1.9 Deployment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Solutions
      • 5.6.2.9 Deployment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Solutions
      • 5.6.3.9 Deployment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Solutions
      • 5.6.4.9 Deployment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Solutions
      • 5.6.5.9 Deployment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 bioMerieux
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Luminex Corporation
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Alere Inc
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 OpGen
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Accelerate Diagnostics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Meridian Bioscience
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 T2 Biosystems
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Mobidiag
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Becton Dickinson
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Roche Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Siemens Healthineers
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Bruker Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Qiagen
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Abbott Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us